- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Palmheld and handheld join Siemens ultrasound
The palm-sized Acuson P10 ultrasound scanner appears this week as a commercial product from Siemens Medical Solutions along with the laptop-based Acuson P50. The P50 is designed for mobile environments but is outfitted with diagnostic-level capabilities, including high-quality gray-scale as well as color and Doppler imaging. Its primary applications will be in cardiology and vascular imaging.
The palm-sized Acuson P10 ultrasound scanner appears this week as a commercial product from Siemens Medical Solutions along with the laptop-based Acuson P50. The P50 is designed for mobile environments but is outfitted with diagnostic-level capabilities, including high-quality gray-scale as well as color and Doppler imaging. Its primary applications will be in cardiology and vascular imaging.
The much smaller P10 is designed as a complementary diagnostic tool in initial patient workup and can play a role in emergency care, obstetrics, and cardiology. Because of its portability, it also could be used in ambulances and Medevac helicopters as well as in intensive care units. Weighing only 1.6 pounds, the pocket-size device is outfitted with a flip-up screen. It appeared at last year's meeting as a work-in-progress and was released as a commercial offering in September.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.
